Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Back to dashboard
Company Information
About this company
Key people
Martin D. Madaus
Independent Chairman of the Board
Rohin Mhatre
Independent Director
Olivier Loeillot
President, Chief Executive Officer, Director
Jason K. Garland
Chief Financial Officer
James R. Bylund
Chief Operating Officer
Brian Robb Douglass
Senior Vice President, Chief Product Officer
Ralf Kuriyel
Senior Vice President - Research and Development
Nicolas M. Barthelemy
Independent Director
Konstantin Konstantinov
Independent Director
Carrie Eglinton Manner
Independent Director
Click to see more
Key facts
- Shares in issue63.49m
- EPICRGEN
- ISINUS7599161095
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$10.62bn
- Employees2,000
- ExchangeNASDAQ
- IndexS&P 400 Mid Cap, TR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.